Clinical evalution of Oma Ilagam (Internal) and Sangamver Thylam (External)for the managaement of Kalanjapadai(Psoriasis) in childre
Phase 2
Completed
- Conditions
- Health Condition 1: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2021/08/035820
- Lead Sponsor
- OPD IPD Ayothidoss Pandithar hospital National institite of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patient with two or more of the following symptoms
Scaling
Erythema
With or without itching
Candle crease sign positive
Dryness of skin
Cracks followed by itching
Auspitz sign positive
Thickness
Exclusion Criteria
Psoriatic arthritis
Eczema
Psoriasis with evidence od any other skin disease
Fungal infection
Any other systemic disorder
Lesion with secondary infection
Epilepsy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efiicacy of the trial drug is measured by PASI score and improvement in the clinical condition is assured by reducing the degrees of involvement of the body region from 5 to 1Timepoint: 45 days
- Secondary Outcome Measures
Name Time Method Reduction in the remission of the disease and improvement in the qualitu of life in children <br/ ><br>Quality of life will be measured with standard published questionarieTimepoint: Before and after treament assessment in interval of 45 days